{"id":"https://genegraph.clinicalgenome.org/r/3a3f84de-b113-4886-b02b-8be103ec44ecv1.0","type":"EvidenceStrengthAssertion","dc:description":"Approved by Jonathan Berg on 11/8/2017.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3a3f84de-b113-4886-b02b-8be103ec44ec","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2e02ec85-306f-4465-b8f9-a6eb7e4e8056","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2e02ec85-306f-4465-b8f9-a6eb7e4e8056_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10018","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/60fb36d5-f629-4f26-8eb9-65bfc751dda2_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10018","date":"2020-09-01T00:00:00Z","role":"Unpublisher"},{"id":"https://genegraph.clinicalgenome.org/r/2e02ec85-306f-4465-b8f9-a6eb7e4e8056_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10018","date":"2017-11-08T05:00:00.000Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e02ec85-306f-4465-b8f9-a6eb7e4e8056_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e02ec85-306f-4465-b8f9-a6eb7e4e8056_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8980df03-9267-48b0-a583-ae70c6b135c0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b8028ed-d6c3-4440-9b27-fa38e51b4f1b","type":"FunctionalAlteration","dc:description":"A dispase assay was used to assess changes in cell-cell adhesion. Knockdown of SERPINB8 resulted in an increased number of fragmented HaCaT cells post dips treatment compared to control. The amount of fragmentation was comparable to a CSTA knockdown, a gene implicated in Peeling Skin syndrome 4 (exfoliative ichthyosis).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","rdfs:label":"siRNA knockdown of SERPINB8 in keratinocytes"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2e02ec85-306f-4465-b8f9-a6eb7e4e8056_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/643659ed-de8e-4928-8533-768743c610dc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f20ca58b-595c-4df3-8c23-abdfcaaec7d8","type":"Finding","dc:description":"Immunohistochemistry and western blotting using and antibody specific for SERPINB8 shows that is localizes to the nucleus of cells, and is expressed in the epidermis and squamous epithelial cell highly. IT is also expressed in pituitary gland, lung, and liver.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12417609","rdfs:label":"SERPINB8 expression in human tissue","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2e02ec85-306f-4465-b8f9-a6eb7e4e8056_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5efe672-c594-409c-a0b0-d885da8b64b3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The mutation is a missense mutation that is predicted to create an N-terminally truncated isoform A and B, but not affect isoform C of SERPINB8. As a missense mutation it requires functional evidence to receive the default points, but no evidence is reported, and therefore the points have been deducted.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6650d26e-57f6-43ee-a382-2d8a3cf090cc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","rdfs:label":"Family 2: proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"PCR and Sanger sequencing of all coding exons of SERPINB8 were performed.","firstTestingMethod":"PCR","phenotypeFreeText":"Superficial peeling of the palmar and dorsal faces of hands and feet, as well as lower arms. Peeling was painless and easily removed with underlying erythema.","phenotypes":["obo:HP_0007503","obo:HP_0010783"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a5efe672-c594-409c-a0b0-d885da8b64b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","allele":{"id":"https://genegraph.clinicalgenome.org/r/9509cd63-65a9-4350-853b-9bb4f52546ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198833.1(SERPINB8):c.2T>C (p.Met1Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/254199"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2e02ec85-306f-4465-b8f9-a6eb7e4e8056_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dacc83a-d276-4815-b823-cdfc8d426e45_proband_segregation","type":"FamilyCosegregation","dc:description":"While the pedigree does not fully show all the genotyping, the text states that the father and 4 healthy siblings were genotyped and found to be heterozygous (an unaffected). This leads to at least 4/5 unaffected individuals being genotyped , and 3 individuals being affected with the ballelic genotype. One siblings mutational status is unknown","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","rdfs:label":"Family 3","estimatedLodScore":1.7,"family":{"id":"https://genegraph.clinicalgenome.org/r/3dacc83a-d276-4815-b823-cdfc8d426e45","type":"Family","rdfs:label":"Family 3","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/f790184d-7523-4816-be62-38284989f180","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","rdfs:label":"Family 3- II:6","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"detectionMethod":"Exome sequencing was performed on II:6 and I:2. Sanger sequencing was used to confirm mutation status for the remaining family members.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Age of onset was between 4-6 months old. Superficial white scale with significant erythema was noted. Diffuse yellowish hyperkeratotic plaques over the palms and soles were observed.","phenotypes":"obo:HP_0045059","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/11a8132b-8f7a-44df-8c96-867761eed2b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8e4622f-ee07-4177-83ae-e9389b5b0bf1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198833.1(SERPINB8):c.850C>T (p.Arg284Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/254200"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Age of onset was between 4-6 months old. Superficial white scale with significant erythema was noted. Diffuse yellowish hyperkeratotic plaques over the palms and soles were observed.","phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0045059","proband":{"id":"https://genegraph.clinicalgenome.org/r/f790184d-7523-4816-be62-38284989f180"}},{"id":"https://genegraph.clinicalgenome.org/r/11eca2d6-8e53-4128-8979-b605068963ce_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","rdfs:label":"Family 1","estimatedLodScore":1.1,"family":{"id":"https://genegraph.clinicalgenome.org/r/11eca2d6-8e53-4128-8979-b605068963ce","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/1730cf16-23ba-4fbb-8850-663436821c66","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","rdfs:label":"Family 1-II:2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"detectionMethod":"High-resolution homozygosity mapping, followed by whole exam sequencing. The mutation was confirmed by PCR and Sanger sequencing.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Superficial peeling of the palmar and dorsal faces of hands and feet. Peeling was painless and easily removed with underlying erythema.","phenotypes":["obo:HP_0007503","obo:HP_0010783"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e9650c36-5387-4aab-986e-e2e79cd68173_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","allele":{"id":"https://genegraph.clinicalgenome.org/r/eaaa8b22-adc4-4ca6-8baf-a918db870c9d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198833.1(SERPINB8):c.947delA (p.Lys316Serfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/254198"}}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Superficial peeling of the palmar and dorsal faces of hands and feet. Peeling was painless and easily removed with underlying erythema.","phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0007503","obo:HP_0010783"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1730cf16-23ba-4fbb-8850-663436821c66"}},{"id":"https://genegraph.clinicalgenome.org/r/1be9ad99-c16f-4311-9cbe-1684f19e1d6f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27476651","rdfs:label":"Family 2","family":{"id":"https://genegraph.clinicalgenome.org/r/1be9ad99-c16f-4311-9cbe-1684f19e1d6f","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6650d26e-57f6-43ee-a382-2d8a3cf090cc"}},"phenotypeFreeText":"Superficial peeling of the palmar and dorsal faces of hands and feet, as well as lower arms. Peeling was painless and easily removed with underlying erythema.","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0007503","obo:HP_0010783"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6650d26e-57f6-43ee-a382-2d8a3cf090cc"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e9650c36-5387-4aab-986e-e2e79cd68173_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Because the identified frameshift mutation occurs in the penultimate exon (exon 7) of SERPINB8 it is not predicted to undergo NMD, therefore a gene product/ protein product will be made. For this reason I am downgrading the points. Also, no functional evidence has been provided for this particular mutation, and it has a high frequency amongst Africans in ExAC and was noted by the authors to be present in homozygosity in 2 patients from their healthy, control cohort.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1730cf16-23ba-4fbb-8850-663436821c66"}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/11a8132b-8f7a-44df-8c96-867761eed2b5_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f790184d-7523-4816-be62-38284989f180"}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1.75}],"evidenceStrength":"Limited","sequence":345,"specifiedBy":"GeneValidityCriteria5","strengthScore":2.75,"subject":{"id":"https://genegraph.clinicalgenome.org/r/I3N7sBokT9Y","type":"GeneValidityProposition","disease":"obo:MONDO_0017339","gene":"hgnc:8952","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_60fb36d5-f629-4f26-8eb9-65bfc751dda2-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}